Nuvaira
Nuvaira, Inc. is a privately held medical device company headquartered in Minneapolis, Minnesota, founded in 2008 to treat overactive airway nerves in people living with chronic obstructive pulmonary disease (COPD). Its dNerva Lung Denervation System is a catheter-based, radiofrequency device used in a bronchoscopic procedure called Targeted Lung Denervation (TLD), which the FDA has designated a Breakthrough Device. The company holds more than 70 issued and pending patents worldwide, has treated over 500 patients across its AIRFLOW clinical program, and is currently running the pivotal AIRFLOW-3 trial. Nuvaira sells a regulated physical therapeutic device to hospitals and interventional pulmonologists; it publishes no developer program, public API, SDK, or machine-readable API contract.
Nuvaira is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health, Healthcare, and Respiratory.
Nuvaira’s developer surface includes engineering blog, support, and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.